Main
>
ONCOLOGY (**)
>
Leukemia>Myeloid>Chronic>Ph+ *
>
Treatment
>
Co.: CH. N. Brand Nilotinib
>
Mechanism: Bcr-Abl Tyrosine Kinase
Inhibition
Mechanism: Bcr-Abl Tyrosine Kinase's products
This section has no products